# C-TIL051 in Non-Small Cell Lung Cancer

> **NCT05676749** · PHASE1 · TERMINATED · sponsor: **AbelZeta Inc.** · enrollment: 1 (actual)

## Conditions studied

- Metastatic Non Small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** C-TIL051

## Key facts

- **NCT ID:** NCT05676749
- **Lead sponsor:** AbelZeta Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-29
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05676749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05676749, "C-TIL051 in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05676749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*